MedTrace Logo

Intervention on Caregivers Caring for Patients Poststroke With Upper Limb Apraxia

NCT02307019 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2018-10-05

No results posted yet for this study

Summary

The purpose of this study is to analyze the effects of a intervention on a specific health prevention/intervention program aimed at caregivers of mild and moderate patients post stroke with upper limb apraxia in comparison to a control group with a no specific formation in that kind of patients.

Conditions

  • Performance Anxiety
  • Emotional Stress

Interventions

OTHER

Program on specific prevention of health

The intervention will be centered in provide effective tools to manage each situation presented while a caregiver cares for patients poststroke with upper limb apraxia. Moreover, the workshops will be focused on the balance between the assistance provided by the caregiver and the improvement and the increase the autonomy and independence of the patients. Finally, we will provide skills and strategies to the caregiver for enhancing the environment adaptation of the patients.

OTHER

Program on general prevention of health

The general health educative program will consist in an educational workshop for caregivers where they are taught the habitual guidelines to caring for patients in situation of dependency.

Sponsors & Collaborators

  • Universidad de Granada

    lead OTHER

Principal Investigators

  • Mª Encarnacion ME Aguilar, PhD · Department of Physiotherapy. Faculty of Sciences of Health. University of Granada (Granada). Spain

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2018-09-30
Completion
2018-09-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02307019 on ClinicalTrials.gov